What is serotonin syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

What is Serotonin Syndrome

Serotonin syndrome is a potentially life-threatening drug toxicity reaction caused by excessive serotonin activity in the central nervous system, typically triggered by serotonergic medications used alone at high doses, in combination with other serotonergic agents, or with monoamine oxidase inhibitors (MAOIs). 1

Pathophysiology and Etiology

Serotonin syndrome results from excessive stimulation of serotonin receptors, particularly 5-HT1A and 5-HT2A receptors, in both the central nervous system and peripherally 2. The condition is non-idiosyncratic and predictable, meaning it follows known pharmacological principles rather than being an unpredictable allergic reaction 2.

Common Precipitating Agents

The syndrome occurs most frequently when combining:

  • MAOIs (phenelzine, isocarboxazid, moclobemide, isoniazid, linezolid) with any other serotonergic drug - this is the highest risk combination 1
  • Multiple serotonergic antidepressants (SSRIs, SNRIs, TCAs, atypical antidepressants) 1
  • Opioid analgesics with serotonergic properties (tramadol, meperidine, methadone, fentanyl) 1
  • Stimulants (amphetamines, possibly methylphenidate) 1
  • Over-the-counter medications (dextromethorphan, chlorpheniramine, St. John's wort, L-tryptophan) 1
  • Illicit drugs (ecstasy, methamphetamine, cocaine, LSD) 1

Clinical Presentation

The classic triad consists of mental status changes, autonomic hyperactivity, and neuromuscular abnormalities 2. However, the presentation is extremely variable, and all three components may not occur simultaneously 2.

Specific Clinical Features

Mental Status Changes:

  • Confusion, agitation, anxiety
  • Agitated delirium 1

Neuromuscular Hyperactivity:

  • Clonus and hyperreflexia - these are highly diagnostic when present with serotonergic drug use 2
  • Myoclonus (occurs in 57% of cases - the most common finding) 2
  • Tremors
  • Muscle rigidity (increased tone, lower extremities greater than upper extremities) 2

Autonomic Hyperactivity:

  • Hypertension, tachycardia, arrhythmias
  • Tachypnea
  • Diaphoresis, shivering
  • Hyperthermia (elevated temperature ≤41.1°C) 2
  • Vomiting, diarrhea 1

Timing

Symptoms typically arise within 24 to 48 hours after combining medications or increasing doses, though onset can range from minutes to hours (usual: 6-24 hours) 2, 1, 2, 1.

Diagnosis

Diagnosis is entirely clinical - there are no pathognomonic laboratory or radiographic findings 2. The Hunter Criteria have higher sensitivity (84%) and specificity (97%) than older Sternbach criteria 2.

Modified Dunkley (Hunter) Criteria

Diagnosis requires serotonergic drug use within the last 5 weeks PLUS any of the following 2:

  • Tremor AND hyperreflexia
  • Spontaneous clonus
  • Muscle rigidity, temperature >38°C, AND either ocular clonus or inducible clonus
  • Ocular clonus AND either agitation or diaphoresis
  • Inducible clonus AND either agitation or diaphoresis

Critical Differential Diagnoses

Distinguish serotonin syndrome from 2:

Neuroleptic Malignant Syndrome (NMS):

  • Onset over days (1-7 days) vs. hours for SS
  • "Lead pipe" rigidity vs. hyperreflexia/clonus in SS
  • Bradyreflexic vs. hyperreflexic
  • Caused by dopamine antagonists vs. proserotonergic drugs

Malignant Hyperthermia:

  • Inherited condition triggered by anesthetics
  • Higher fever (≤46°C vs. ≤41.1°C)
  • Rigor mortis-like rigidity

Anticholinergic Syndrome:

  • Mild fever (<38.8°C)
  • Hot, dry skin vs. diaphoresis
  • Mydriasis with dry mucous membranes
  • Normal muscle tone

Severity and Complications

Mortality rate is approximately 11% 2. Approximately one-quarter of patients require intubation, mechanical ventilation, and ICU admission 2.

Severe Cases (Temperature >41.1°C) Present With:

  • Rhabdomyolysis with elevated creatine kinase
  • Metabolic acidosis
  • Elevated serum aminotransferases
  • Renal failure with elevated creatinine
  • Seizures
  • Disseminated intravascular coagulopathy 2

Management

Immediate discontinuation of all serotonergic agents is the cornerstone of treatment 2.

Supportive Care Algorithm

For All Cases:

  1. Stop all serotonergic medications immediately
  2. Aggressive IV hydration
  3. Benzodiazepines for agitation (first-line agent) 2
  4. External cooling measures for hyperthermia (cooling blankets)
  5. Continuous cardiac monitoring 1

For Severe Cases (Temperature >41.1°C):

  1. Emergency sedation
  2. Neuromuscular paralysis
  3. Intubation and mechanical ventilation 2

Pharmacological Antagonist:

  • Cyproheptadine (serotonin2A antagonist) may be considered at adult dosages 2

Critical Pitfall

Avoid physical restraints - they exacerbate isometric muscle contractions, worsening hyperthermia and lactic acidosis, thereby increasing mortality 2.

Prognosis

Most mild to moderate cases resolve within 24-72 hours after appropriate treatment and drug discontinuation 1. The prognosis is favorable with early recognition and prompt intervention.

Prevention Strategies

  • Start second serotonergic drugs at low doses and increase slowly
  • Monitor closely in the first 24-48 hours after dosage changes 1
  • Absolutely avoid combining MAOIs with any other serotonergic drug 1
  • Exercise extreme caution when combining two or more non-MAOI serotonergic agents
  • Educate patients and families about medication storage and potential interactions 1

References

1
Guideline

clinical practice guideline for the assessment and treatment of children and adolescents with anxiety disorders.

Journal of the American Academy of Child and Adolescent Psychiatry, 2020

Related Questions

Which drugs commonly cause serotonin syndrome, what are their incidence rates in the general population and among medication users (presented in a table), can serotonin syndrome occur from non‑medication sources, what is its prognosis, and what is the most effective antidote?
Can you create a handout on serotonin syndrome?
In serotonin syndrome, does the QRS interval become widened?
In an intubated patient with elevated peak airway pressures, what are the clinical features of serotonin syndrome and how should it be treated?
How does serotonin syndrome present during general anesthesia for spine surgery?
In a patient with severe aspiration risk, should bilevel positive airway pressure (BiPAP) or continuous positive airway pressure (CPAP) be used?
What are the differences between the FloTrac (arterial‑based cardiac output monitoring system) and the PiCCO (Pulse contour cardiac output) systems?
How should I manage a patient who develops an allergic reaction when the offending medication is unknown?
In otherwise healthy adults taking 1,000–2,000 IU of vitamin D daily, is it necessary to also take vitamin K (or vitamin K2) for proper calcium utilization and bone health, and are there special considerations for patients on warfarin?
What is the appropriate management for a patient with a two‑year history of chronic urinary tract infections, allergies to erythromycin, cephalexin (Ceclor), codeine, penicillins, and tramadol (Ultram), a recent urine culture showing moderate growth of Enterobacter and yeast, and prior exposure to nitrofurantoin (Macrobid), trimethoprim‑sulfamethoxazole (Bactrim), cephalexin (Keflex), and levofloxacin?
When can I expect symptoms to improve after stopping lurasidone (Latuda) eight days ago?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.